Han BiomedicalROCO:6999 +0.17%25 ROA % is 8.27% as of Dec. 2025, which is 10% below its 10-year median of 9.18. GuruFocus rates ROCO:6999 with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 1,412 Biotechnology companies, Han Biomedical ranks better than 90.72% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Han Biomedical's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$25.3 Mil.
Han Biomedical's average Total Assets over the quarter that ended in Dec. 2025 was NT$306.2 Mil. Therefore, Han Biomedical's annualized ROA % for the quarter that ended in Dec. 2025 was 8.27%.
The historical rank and industry rank for Han Biomedical's ROA % or its related term are showing as below:
ROCO:6999'
s ROA % Range Over the Past 10 Years
Min: 6.19 Med: 9.18 Max: 9.75
Current: 7.65
During the past 5 years, Han Biomedical's highest ROA % was 9.75%. The lowest was 6.19%. And the median was 9.18%.
ROCO:6999's ROA % is ranked better than 90.72% of 1412
companies
in the Biotechnology industry
Industry Median: -32.57
vs ROCO:6999: 7.65
Han Biomedical (ROCO:6999) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Han Biomedical ROA % Related Terms
Han Biomedical ROA % Historical Data
* Premium members only.
The historical data trend for Han Biomedical's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Han Biomedical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Han Biomedical ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Han Biomedical's ROA % distribution charts can be found below:
* The bar in red indicates where Han Biomedical's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Han Biomedical (ROCO:6999) has a ROA % of 8.27% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Han Biomedical and its competitors. This is 10% below median its historical median of 9.18. Over the past decade, Han Biomedical's ROA % has ranged from 6.19 to 9.75. According to the industry distribution chart, Han Biomedical ranks #131 out of 1412 companies in the Biotechnology industry, placing it in the top 9.3%.
Is Han Biomedical's ROA % too high?
Han Biomedical's current ROA % of 8.27% is 10% below median its 10-year median of 9.18. Over the past 10 years, this metric has ranged from a low of 6.19 to a high of 9.75. Based on the distribution chart, Han Biomedical ranks #131 out of 1412 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Han Biomedical has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #131 out of 1412 companies for ROA %. This places Han Biomedical in the top 9% of its industry — outperforming the majority of peers. Historically, Han Biomedical's own ROA % has ranged from 6.19 to 9.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Han Biomedical and its competitors. Han Biomedical's current ROA % is 8.27%, which is 10% below median its own 10-year median of 9.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current ROA % of 8.27%. The current ROA % is 8.27%, which is 10% below median its 10-year median of 9.18. Han Biomedical's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current ROA % is 8.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6999 has been successfully added to your 